IRIS
DEFERRARI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.003
AS - Asia 2.374
NA - Nord America 1.970
SA - Sud America 200
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 42
OC - Oceania 2
Totale 27.727
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 22.613
US - Stati Uniti d'America 1.826
SG - Singapore 1.016
CN - Cina 612
VN - Vietnam 300
BD - Bangladesh 219
FR - Francia 192
BR - Brasile 124
HK - Hong Kong 96
CH - Svizzera 43
DE - Germania 42
CA - Canada 41
AR - Argentina 31
MX - Messico 30
GB - Regno Unito 25
FI - Finlandia 21
JP - Giappone 21
IN - India 15
ID - Indonesia 14
IQ - Iraq 14
CR - Costa Rica 13
CO - Colombia 12
EC - Ecuador 12
JM - Giamaica 11
NL - Olanda 11
ZA - Sudafrica 11
HN - Honduras 10
PH - Filippine 10
PL - Polonia 9
SC - Seychelles 9
VE - Venezuela 9
GT - Guatemala 8
DZ - Algeria 7
IE - Irlanda 7
MA - Marocco 7
ES - Italia 6
RU - Federazione Russa 6
UA - Ucraina 6
AZ - Azerbaigian 5
TR - Turchia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
JO - Giordania 4
KR - Corea 4
NI - Nicaragua 4
NP - Nepal 4
PK - Pakistan 4
PR - Porto Rico 4
PY - Paraguay 4
SA - Arabia Saudita 4
CL - Cile 3
DK - Danimarca 3
PA - Panama 3
SV - El Salvador 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
EG - Egitto 2
GP - Guadalupe 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
UZ - Uzbekistan 2
AD - Andorra 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LV - Lettonia 1
MF - Saint Martin 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 27.591
Salva come PNG Salva come JPEG
Città #
Genova 14.508
Genoa 4.451
Rapallo 2.153
Vado Ligure 1.298
San Jose 563
Singapore 513
Lauterbourg 182
Ashburn 169
New York 100
Beijing 95
Hong Kong 87
Hanoi 85
Ho Chi Minh City 78
Santa Clara 59
Bordighera 51
Zurich 43
Los Angeles 42
Frankfurt am Main 35
Chicago 21
Helsinki 21
Rome 21
Dallas 20
Mexico City 20
Phoenix 19
Tokyo 18
Tianjin 16
Buffalo 15
Orem 13
Philadelphia 13
São Paulo 13
Da Nang 12
Milan 12
Haiphong 11
Atlanta 10
Brooklyn 10
Council Bluffs 10
Houston 10
San Francisco 10
Baghdad 9
Naples 9
Washington 9
Amsterdam 7
Biên Hòa 7
Charlotte 7
City of London 7
Dublin 7
Fort Worth 7
Guayaquil 7
Las Vegas 7
San Antonio 7
San José 7
Toronto 7
Denver 6
Kingston 6
Lexington 6
The Bronx 6
Jacksonville 5
Johannesburg 5
Kansas City 5
London 5
Montreal 5
Orangeburg 5
St Louis 5
Turin 5
Bologna 4
Guangzhou 4
Iowa City 4
Louisville 4
Madrid 4
Newark 4
Orland Park 4
Pasadena 4
Plainfield 4
Richmond 4
San Pedro Sula 4
Tampa 4
Topeka 4
Trieste 4
Amman 3
Baku 3
Bogotá 3
Brasília 3
Bắc Ninh 3
Cao Lanh 3
Cardiff 3
Chaguanas 3
Charleston 3
Cincinnati 3
Concord 3
Des Moines 3
Guatemala City 3
Harrisburg 3
Managua 3
Manchester 3
Minneapolis 3
Mumbai 3
Pittsburgh 3
Quảng Ngãi 3
Rochester 3
Rockford 3
Totale 25.097
Salva come PNG Salva come JPEG
Nome #
L'AMMONIOGENESI RENALE NELL'UOMO 339
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy 226
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 213
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 207
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 206
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 205
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 192
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 191
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 189
C-reactive protein and target organ damage in untreated patients with primary hypertension. 186
Interorgan exchange of aminothiols in humans 183
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 182
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 180
Renal and cardiac abnormalities in primary hypertension 179
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 179
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 179
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 177
Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis. 176
Inter-organ leptin exchange in humans 175
Blood pressure variability and multiple organ damage in primary hypertension 173
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. 171
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 171
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 168
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 167
INDIVIDUAZIONE DEL RUOLO DELLA GLUTAMINASI FOSFATO-DIPENDENTE E DELLA GLUTAMINASI FOSFATO-INDIPENDENTE NELLA PRODUZIONE RENALE DI AMMONIACA 166
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 165
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 165
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 163
PROTEIN TURNOVER IN THE HUMAN KIDNEY 162
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 161
Amino acid imbalance in patients with chronic renal failure. 161
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 161
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 160
136) CKD awareness and blood pressare control in the primari care hypertensive population 160
Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II 159
Creatinine clearance and early signs of target organ damage in primary hypertension 158
Sub-clinical organ damage in hypertension and obesity 158
Mechanisms of renal ammonia production and protein turnover 158
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 157
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 157
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 156
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 156
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 154
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 154
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 154
Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study 152
Mild renal dysfunction and renal vascular resistance in primary hypertension 152
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 152
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 152
Apoptosis in the kidneys of patients with type 2 diabetic nephropathy. 151
Phenylalanine hydroxylation across the kidney in humans 150
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 149
Renal ammoniagenesis in an early stage of metabolic acidosis in man 148
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestion 148
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 148
[Activity of renal enzymes producing ammonia from glutamine in the absence of phosphate: 2. Effect of phosphate dependent glutaminase inhibition by heating]. 147
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 147
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 146
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 145
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 145
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 144
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 144
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 144
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 143
Disposal of exogenous amino acids by muscle in patients with chronic renal failure 143
EFFECTS OF HEMODIALYSIS ON GUANIDINO-PROPIONIC ACID METABOLISM 143
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 142
BRAIN METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY 142
RENAL METABOLISM OF C-PEPTIDE IN MAN 142
Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients 142
AMINO ACID BIOSYNTHESIS 141
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 141
[Acute effects of peritoneal dialysis on muscle protein turnover]. 141
Emerging therapeutic strategies in diabetic nephropathy 141
Serum uric acid as a marker of target organ damage in primary hypertension 141
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 140
Renal ammoniagenesis during the adaptation to metabolic acidosis in man. 140
Renal ammoniagenesis in humans with chronic potassium depletion 140
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure 139
AMINO ACID METABOLISM IN RENAL FAILURE 138
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 138
Testosterone promotes apoptotic damage in human renal tubular cells 138
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 137
EFFETTI DELL'INSUFFICIENZA RENALE CRONICA SUL METABOLISMO DELLA TIROSINA E DELLA FENILALANINA. 137
Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency 137
EFFETTI DELLE VARIAZIONI DEL pH DEL BAGNO DI DIALISI SULL'EQUILIBRIO ACIDO-BASE (EAB) DEI PAZIENTI IN CORSO DI EMODIALISI 136
Abnormalities in blood amino acid profile after a protein meal in patients with chronic renal failure. Kidney Int Suppl. 1989 Nov;27:S212-5. 136
EFFECT OF AMINO ACID INGESTION ON BLOOD AMINO ACID PROFILE IN PATIENTS WITH CHRONIC RENAL FAILURE 136
LEG METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL FAILURE 136
WHOLE BODY AND ORGAN PROTEIN TURNOVER IN CHRONIC RENAL FAILURE 135
Metabolismo inter-organo dell'omocisteina totale e degli aminoacidi solforati nell'uomo 135
ABNORMALITIES OF AMINO ACID AND KETO ACID METABOLISM IN CHRONIC RENAL FAILURE 135
Ammonia and amino acid metabolism y the portal-vein-drained viscera in chronic renal insufficiency. 135
Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney 135
Blood pressure load, vascular permeability and target organ damage in primary hypertension 134
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure 134
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein synthesis and degradation 134
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. 133
TT virus infection in haemodialysis patients 133
LEUCINE METABOLISM AND PROTEIN DYNAMICS IN THE HUMAN KIDNEY 132
Totale 15.728
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.279
article - articoli 75.753
book - libri 0
conference - conferenze 4.918
curatela - curatele 0
other - altro 777
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.831
Totale 172.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.323 0 0 142 322 126 187 192 589 69 215 152 329
2022/20232.571 240 115 30 265 421 489 3 238 462 14 248 46
2023/20241.058 66 165 19 108 80 151 43 88 75 9 100 154
2024/20253.055 45 254 86 185 501 322 245 402 142 159 348 366
2025/20265.368 609 109 242 438 688 613 962 253 313 483 271 387
2026/20271.034 554 126 354 0 0 0 0 0 0 0 0 0
Totale 27.727